Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial-Reference-Cited by-同舟云学术

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

Published:2012-05 Issue:5 Volume:13 Page:501-508
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Madan Ravi A,Mohebtash Mahsa,Arlen Philip M,Vergati Matteo,Rauckhorst Myrna,Steinberg Seth M,Tsang Kwong Y,Poole Diane J,Parnes Howard L,Wright John J,Dahut William L,Schlom Jeffrey,Gulley James L

Publisher

Elsevier BV

Subject

Oncology

Reference28 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer;Small;J Clin Oncol,2006

3. Sipuleucel-T immunotherapy for castration-resistant prostate cancer;Kantoff;N Engl J Med,2010

4. Overall survival analysis of a phase II randomized controlled trial of a poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer;Kantoff;J Clin Oncol,2010

5. Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer;Gulley;Cancer Immunol Immunother,2010

Cited by 307 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomaterial‐Based Therapeutic Delivery of Immune Cells;Advanced Healthcare Materials;2024-06-05

2. Clinical research regarding the treatment of prostate cancer;Revisiones en Cáncer;2024

3. Vaccine-induced effects on regulatory T cell function: autoimmune perspective;Regulatory T Cells and Autoimmune Diseases;2024

4. A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer;Cancer Drug Resistance;2023-09-25

5. New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy (Review);International Journal of Oncology;2023-06-12